Cormorant Asset Management, LP Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$1.3T
Holdings
49
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NKTREURNEKTAR THERAPEUTICS | 4,094,100 | $435.0B | 32.43% | Call |
| 2 | ANABANAPTYSBIO INC | 1,233,422 | $128.4B | 9.57% | Call |
| 3 | APLSAPELLIS PHARMACEUTICALS INC | 4,088,229 | $90.4B | 6.74% | |
| 4 | MRTXEURMIRATI THERAPEUTICS INC | 1,918,350 | $58.9B | 4.39% | |
| 5 | IFRXINFLARX NV | 1,399,030 | $40.3B | 3.01% | |
| 6 | 2L9BLUEPRINT MEDICINES CORP | 432,063 | $39.6B | 2.95% | |
| 7 | SG7SAGE THERAPEUTICS INC | 239,619 | $38.6B | 2.88% | |
| 8 | —MYOKARDIA INC | 767,363 | $37.4B | 2.79% | |
| 9 | —DICERNA PHARMACEUTICALS INC | 3,600,954 | $34.4B | 2.57% | |
| 10 | TBPHTHERAVANCE BIOPHARMA INC | 1,300,000 | $31.5B | 2.35% | |
| 11 | RCKTROCKET PHARMACEUTICALS INC | 1,519,891 | $28.5B | 2.12% | |
| 12 | GTHXEURG1 THERAPEUTICS INC | 719,985 | $26.7B | 1.99% | |
| 13 | OMEROMEROS CORP | 2,283,118 | $25.5B | 1.90% | Call |
| 14 | ASNDASCENDIS PHARMA A S | 371,739 | $24.3B | 1.81% | |
| 15 | —AVEXIS INC | 192,094 | $23.7B | 1.77% | |
| 16 | ARGXARGENX SE | 278,536 | $22.4B | 1.67% | |
| 17 | —QUOTIENT LTD | 4,290,852 | $20.2B | 1.51% | |
| 18 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,880,880 | $20.2B | 1.50% | |
| 19 | —TESARO INC | 350,000 | $20.0B | 1.49% | |
| 20 | VNDAVANDA PHARMACEUTICALS INC | 957,821 | $16.1B | 1.20% | |
| 21 | NBIXNEUROCRINE BIOSCIENCES INC | 191,112 | $15.8B | 1.18% | |
| 22 | QTRXQUANTERIX CORP | 847,789 | $14.4B | 1.08% | |
| 23 | —MENLO THERAPEUTICS INC | 336,714 | $12.7B | 0.94% | |
| 24 | ARRYEURARRAY BIOPHARMA INC | 668,743 | $10.9B | 0.81% | |
| 25 | —AUDENTES THERAPEUTICS INC | 322,945 | $9.7B | 0.72% | |
| 26 | RETAEURREATA PHARMACEUTICALS INC | 450,000 | $9.2B | 0.69% | |
| 27 | ACRSACLARIS THERAPEUTICS INC | 525,538 | $9.2B | 0.69% | |
| 28 | —ABEONA THERAPEUTICS INC | 549,404 | $7.9B | 0.59% | |
| 29 | —BIOHAVEN PHARMACTL HLDG CO L | 284,735 | $7.3B | 0.55% | |
| 30 | COLLCOLLEGIUM PHARMACEUTICAL INC | 286,668 | $7.3B | 0.55% | |
| 31 | GBYSANGAMO THERAPEUTICS INC | 382,192 | $7.3B | 0.54% | |
| 32 | ZLABZAI LAB LTD | 333,166 | $7.1B | 0.53% | |
| 33 | —KADMON HOLDINGS INC | 1,648,432 | $7.0B | 0.52% | |
| 34 | —GEMPHIRE THERAPEUTICS INC | 1,041,635 | $6.8B | 0.51% | |
| 35 | —CONTRAFECT CORP | 3,392,234 | $5.4B | 0.40% | |
| 36 | HRTXHERON THERAPEUTICS INC | 191,108 | $5.3B | 0.39% | |
| 37 | SLDBSOLID BIOSCIENCES INC | 685,958 | $5.1B | 0.38% | |
| 38 | ARNAEURARENA PHARMACEUTICALS INC | 125,000 | $4.9B | 0.37% | |
| 39 | —INTEC PHARMA LTD JERUSALEM | 773,816 | $4.9B | 0.36% | |
| 40 | TREURTRILLIUM THERAPEUTICS INC | 573,208 | $4.1B | 0.31% | |
| 41 | NERVGBPMINERVA NEUROSCIENCES INC | 607,903 | $3.8B | 0.28% | |
| 42 | PTGXPROTAGONIST THERAPEUTICS INC | 382,139 | $3.3B | 0.24% | |
| 43 | EOLSEVOLUS INC | 342,400 | $3.1B | 0.23% | |
| 44 | XLRNACCELERON PHARMA INC | 71,667 | $2.8B | 0.21% | |
| 45 | JNCEEURJOUNCE THERAPEUTICS INC | 82,988 | $1.9B | 0.14% | |
| 46 | —MARINUS PHARMACEUTICALS INC | 478,111 | $1.8B | 0.14% | |
| 47 | —ONCOBIOLOGICS INC | 416,666 | $18.0M | 0.00% | |
| 48 | —ONCOBIOLOGICS INC | 416,666 | $15.0M | 0.00% | |
| 49 | —CELLECTAR BIOSCIENCES INC | 52,999 | $6.0M | 0.00% |